As Drug Price Target Deadline Looms, Pharma Companies Weigh Options

As drug price target deadline looms, pharma companies weigh options

Trump's most-favored nation plan would tie U.S. drug prices to those in other countries. Pharma firms await details, worry about consequences.

Proposed Import Tariffs on Pharmaceutical Goods Could Reshape US Supply Chains

The pharmaceutical industry is facing potential challen […] The post Proposed Import Tariffs on Pharmaceutical Goods Could Reshape US Supply Chains first appeared on GeneOnline News. The post Proposed Import Tariffs on Pharmaceutical Goods Could Reshape US Supply Chains appeared first on GeneOnline News.

Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData - Express Pharma

In a bold move to reshape the landscape of pharmaceutical manufacturing in the US, President Donald Trump has signed an executive order on May 5 aimed at streamlining regulatory hurdles for domestic producers while tightening the reins on foreign manufacturers. This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential eff…

Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness, says GlobalData - GlobalData

In a bold move to reshape the landscape of pharmaceutical manufacturing in the US, President Donald Trump has signed an executive order on May 5 aimed at streamlining regulatory hurdles for domestic producers while tightening the reins on foreign manufacturers. This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential eff…